BSW Wealth Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-848
Closed -$330K 335
2025
Q2
$330K Sell
848
-106
-11% -$42.6K 0.05% 228
2025
Q1
$415K Buy
954
+245
+35% +$98.4K 0.06% 186
2024
Q4
$262K Buy
709
+210
+42% +$87.9K 0.04% 256
2024
Q3
$259K Buy
+499
New +$267K 0.04% 252
2024
Q1
Sell
-613
Closed -$289K 305
2023
Q4
$289K Buy
613
+91
+17% +$42.1K 0.06% 208
2023
Q3
$227K Sell
522
-54
-9% -$24.5K 0.05% 216
2023
Q2
$256K Sell
576
-11
-2% -$5.07K 0.05% 208
2023
Q1
$270K Sell
587
-212
-27% -$101K 0.06% 235
2022
Q4
$410K Sell
799
-11
-1% -$5.58K 0.09% 163
2022
Q3
$368K Buy
810
+283
+54% +$135K 0.09% 148
2022
Q2
$254K Buy
527
+55
+12% +$27.2K 0.06% 214
2022
Q1
$232K Sell
472
-20
-4% -$9.14K 0.06% 246
2021
Q4
$228K Buy
+492
New +$207K 0.06% 228

Other funds holding ELV

BSW Wealth Partners's ELV Position: Q3 2025 in Review

BSW Wealth Partners sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 848 shares — an estimated $330K sold.

BSW Wealth Partners first reported a position in ELV in Q4 2021 and held it in 13 quarters. The position peaked at $415K in Q1 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • BSW Wealth Partners reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • BSW Wealth Partners sold 848 Elevance Health shares in Q3 2025, an estimated $330K.
  • BSW Wealth Partners first reported a position in Elevance Health in Q4 2021 and held it in 13 quarters.
  • BSW Wealth Partners's Elevance Health position peaked at $415K in Q1 2025.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on BSW Wealth Partners's 13F filing for Q3 2025, filed 15 Oct 2025.